Process

Details for Australian Patent Application No. 2003248302 (hide)

Owner Delta Biotechnology Limited

Inventors Berezenko, Stephen; Morton, Philip Harvey; Ballance, David James; Veron, Jean-Luc Bernard; Mead, David John; Woodrow, John Rodney; Grandgeorge, Michel Gaston Joseph; Cartwright, Andrew John; Cameron, Jason; Sleep, Darrell; Van Urk, Hendrik

Agent Davies Collison Cave

Pub. Number AU-B-2003248302

Parent 763899

Filing date 23 September 2003

Wipo publication date 30 October 2003

Acceptance publication date 7 September 2006

International Classifications

C07K 14/765 (2006.01) Peptides having more than 20 amino acids

Event Publications

9 October 2003 Complete Application Filed

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003248302

7 September 2006 Application Accepted

  Published as AU-B-2003248302

21 December 2006 Change of Name(s) of Applicant(s), Section 104

  Delta Biotechnology Limited The name of the applicant has been changed to Novozymes Delta Limited

22 March 2007 Standard Patent Sealed

19 November 2009 Assignment Registered

  Novozymes Delta Limited The patent has been assigned to Novozymes Biopharma DK A/S

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003248303-Multidirectional defence system for military aircraft

2003248301-Massage Mat